Xenopus Brachyury (Xbra) plays a key role in mesoderm formation during early development. One factor thought to be involved in the regulation of Xbra is XSIP1, a zinc finger/homeodomain-like DNA-binding protein that belongs to the dEF1 family of transcriptional repressors. We show here that Xbra and XSIP1 are co-expressed at the onset of gastrulation, but that expression subsequently refines such that Xbra is expressed in prospective mesoderm and XSIP1 in anterior neurectoderm. This refinement of the expression patterns of the two genes is due in part to the ability of XSIP1 to repress expression of Xbra. This repression is highly specific, in the sense that XSIP1 does not repress the expression of other regionally expressed genes in the early embryo, and that other members of the family to which XSIP1 belongs, such as dEF1 and its Xenopus homologue ZEB, cannot regulate Xbra expression. The function of XSIP1 was studied further by making an interfering construct comprising the open reading frame of XSIP1 fused to the VP16 transactivation domain. Experiments using this chimeric protein suggest that XSIP1 is required for normal gastrulation movements to occur and for the development of the anterior neural plate. q
Introduction
Xenopus Brachyury (Xbra) is expressed in the presumptive mesoderm of the Xenopus embryo (Smith et al., 1991) and plays an essential role in the formation of this germ layer. Thus, mis-expression of Xbra in prospective ectoderm of the embryo causes cells to form mesodermal cell types and to activate mesoderm-specific genes Smith, 1992, 1994; O'Reilly et al., 1995; Tada et al., 1997) , while interference with Xbra function results in a loss of posterior structures and impairment of notochord differentiation (Conlon et al., 1996) . These observations mark Xbra as a key gene in mesoderm formation, and we have been addressing both its mode of action (Saka et al., 2000; Tada et al., 1998; Tada and Smith, 2000) and its transcriptional regulation, including its ability to respond to the mesoderm-inducing factors activin and FGF (Latinkic et al., 1997; Lerchner et al., 2000; Papin and Smith, 2000) .
One gene that appears to play an important role in the regulation of Xbra is XSIP1 (Eisaki et al., 2000; van Grunsven et al., 2000) , the Xenopus homologue of SIP1 (Lerchner et al., 2000; Verschueren et al., 1999) . SIP1 is a zinc finger/ homeodomain-like DNA-binding protein that belongs to the dEF1 family of transcriptional repressors (Franklin et al., 1994; Remacle et al., 1999) , members of which are involved in cell fate decisions in Drosophila (Fortini et al., 1991; Su et al., 1999) and in vertebrates (Funahashi et al., 1993; Genetta and Kadesch, 1996; Lai et al., 1993; Postigo and Dean, 1997; Sekido et al., 1996; Su et al., 1999; Takagi et al., 1998) . Mutations in human SIP1 have recently been shown to cause a form of Hirschsprung disease (Cacheux et al., 2001; Wakamatsu et al., 2001) . Mouse SIP1 (mSIP1) was originally identified through its ability to interact with receptor-regulated Smad proteins in a ligand-dependent manner . Gel shift analyses show that mSIP1, like dEF1, binds to 5 0 -CACCT sequences in different promoters, including that of Xbra (Verschueren , 1999) . However, high affinity SIP1 binding sites comprise one CACCT and one CACCTG sequence, the orientation and spacing of which can vary. SIP1 binds as a monomer to such elements, with one of its two zinc finger clusters contacting one target sequence and the second cluster contacting the other . Attempts to isolate activin-and FGF-response elements in the Xbra promoter have defined a 150 base pair region in the 5 0 flanking region which confers responsiveness to both factors (Latinkic et al., 1997) . This region contains the bipartite SIP1 binding sequence, and experiments using transgenic Xenopus embryos show that any point mutation that abolishes high affinity binding in vitro causes widespread mis-expression of reporter constructs during early gastrula stages (Lerchner et al., 2000) . These results suggest that SIP1 plays a role in defining the correct expression of Xbra in the marginal zone, and in support of this idea, expression of mSIP1 throughout the Xenopus embryo causes the down-regulation of Xbra . We, and others, have recently isolated the Xenopus homologue of SIP1 (Eisaki et al., 2000; van Grunsven et al., 2000) . Like its mouse homologue, XSIP1 interacts with the MH2 domains of Smad proteins. Expression of XSIP1 is first detectable at the early gastrula stage and transcription then occurs throughout embryogenesis. During early gastrula stages, XSIP1 transcripts are present in prospective neurectoderm, and by the neurula stage expression is high in the neural plate but weak in the dorsal midline. At later stages, transcripts are detected primarily within the neural tube, neural crest and lateral plate mesoderm (van Grunsven et al., 2000) .
In this paper we investigate the role of XSIP1 in Xbra regulation and in mesoderm formation. At the early gastrula stage, the expression patterns of the two genes overlap, but their domains then resolve such that Xbra is expressed in the mesoderm and XSIP1 in the neurectoderm. This observation is consistent with the suggestion that XSIP1 down-regulates Xbra, and we demonstrate that this down-regulation is direct and highly specific.
Attempts to block XSIP1 function by use of antisense morpholino oligonucleotides (Heasman et al., 2000) did not meet with success, and we therefore constructed a dominant-interfering form of SIP1 in which the protein is fused to the VP16 activation domain (see Brickman et al., 2000) . Expression of this construct activates Xbra in Xenopus animal caps and in the intact embryo it causes a reduction in anterior structures. Together, these data show that XSIP1 plays a role in the regulation of Xbra and they shed light on the function of XSIP1 during normal development.
Results

XSIP1 and Xbra are co-expressed at the beginning of gastrulation
Previous work has suggested that XSIP1 might play a role Fig. 1 . Comparison of the expression of Xbra and XSIP1 during gastrulation. Whole-mount in situ hybridisation analysis of Xbra (A-C) and XSIP1 (D-F) at stage 10 (A, D), stage 11 (B, E) and stage 12.5 (C, F). Note that at stage 10 both Xbra and XSIP1 are expressed above the dorsal blastopore lip and that as gastrulation proceeds, they resolve in two distinct expression domains. Sections of embryos stained for XSIP1 RNA (blue) and Xbra protein (brown) show that the two genes are co-expressed above the dorsal lip at stage 10.25 (G, G1: sagittal sections) and resolve in two different domains at stage 12 (H, H1: sagittal sections; I, I1: transverse sections).
in the regulation of Xbra (Lerchner et al., 2000; Verschueren et al., 1999) . To address this question, we first compared the expression patterns of the two genes during gastrula stages. XSIP1 and Xbra RNA were detected by in situ hybridisation, and Xbra protein by means of immunocytochemistry using a specific polyclonal antibody. At the onset of gastrulation, the expression patterns of the two genes overlap, particularly in deep cells above the dorsal blastopore lip, although expression of Xbra extends deeper than does that of XSIP1 (Fig. 1A,D,G,G1 ). Expression of XSIP1 and Xbra in the suprablastoporal endoderm is low (Fig. 1G1) . As gastrulation proceeds, the expression patterns of the two genes resolve into two different domains; XSIP1 is expressed in the neurectoderm, where it delineates the presumptive anterior neural plate, and Xbra protein is present in the non-involuting mesoderm and the future notochord (Fig. 1B-F,H,I ). We note that XSIP1 transcripts are present at lower levels in the dorsal midline (Fig. 1F ,I,I1 and Eisaki et al., 2000; van Grunsven et al., 2000) . The initial coincidence and then resolution of the XSIP1 and Xbra expression patterns are consistent with the idea that the two genes influence each other's expression.
XSIP1 transcription is induced by mesoderm-inducing and neural-inducing signals
XSIP1 expression is detected in the dorsal marginal zone at early gastrula stages and later in neurectoderm and neural tissue (Eisaki et al., 2000; van Grunsven et al., 2000) . The regulation of XSIP1 was examined using the animal cap assay, which showed that XSIP1 is induced by activin, Xbra, noggin and a dominant-negative BMP4 receptor (tBR) ( Fig. 2A-D) . We note that induction of XSIP1 by the mesoderm-inducing signals activin and Xbra is first detectable at stage 10.5 and persists at least until stage 18 ( Fig. 2A,B) . However, induction of XSIP1 by activin or Xbra requires protein synthesis and therefore cannot be said to be 'immediate-early' (data not shown). XSIP1 is induced by a wide range of concentrations of both activin and Xbra ( Fig. 2A,B) .
Interestingly, significant induction of XSIP1 by neuralinducing factors such as noggin and tBR is only detectable from stage 12 (Fig. 2C,D) . This later expression suggests that XSIP1 has two distinct expression domains and two modes of activation. Consistent with this suggestion, we observe that noggin can induce expression of XSIP1 in isolated ventral marginal zone regions, and that the expression in this region first occurs at stage 10.5 (Fig. 2C) . We interpret this activation as being due to the dorsalisation of ventral mesoderm, rather than to the induction of neural tissue.
Mis-expression of XSIP1 affects Xbra expression and function in a specific manner
The gradual resolution of the Xbra and XSIP1 expression domains is consistent with the observation that mSIP1 negatively regulates transcription of Xbra . To substantiate this idea, Xbra expression was analysed in embryos or animal caps expressing mSIP1. In situ hybridisation analysis shows that Xbra is down-regulated in SIP1-expressing cells (Fig. 3A,B) , and a similar down-regulation is observed by RNAase protection in both whole embryos and in activin-treated animal caps (Fig. 3C,D) . This repression of Xbra can occur at any posi- tion of the marginal zone (data not shown) and is not a general property of the dEF1 family, because mis-expression of mouse dEF1 itself, or of its Xenopus homologue ZEB, do not cause down-regulation of Xbra (Fig. 3E) .
Down-regulation of Xbra expression by mSIP1 appears to be direct, because it is not affected by treatment with cycloheximide (Fig. 3F ). This is consistent with the observation that SIP1 can bind to the Xbra promoter .
The down-regulation of Xbra expression by SIP1 raises the possibility that SIP1 is a general inhibitor of mesoderm formation. To investigate this possibility we tested the effects of SIP1 on expression of the ventral marker Vent1, the pan-mesodermal marker Xwnt11, the organiser-specific genes goosecoid and chordin, the mesendodermal marker Bix4, the ventral mesodermal marker XWnt8 and the endodermally expressed Xsox17a (Fig. 4) . Analysis was carried out at stage 10.5 by RNAase protection or by in situ hybridisation. SIP1 proved to down-regulate slightly the expression of Bix4 and goosecoid (Fig. 4A ), but this was minor compared with the effects on Xbra. Interestingly, inspection of the Bix4 promoter reveals an XSIP1 binding site (Tada et al., 1998) . Together, our results indicate that the effects of XSIP1 on the regulation of Xbra are highly specific.
We next tested the effects of XSIP1 over-expression on whole embryos. Xenopus embryos injected at the two-cell stage with RNA encoding XSIP1 developed normally until the early gastrula stage. However, such embryos failed to complete gastrulation ( Fig. 5A-D) and by tadpole stages posterior structures were greatly reduced (Fig. 5E,F) , as were the eyes ( Fig. 5G-I ). Whole-mount immunocytochemistry using the notochord-specific antibody MZ15 (Fig. 5J) showed that approximately 15% of XSIP1-injected embryos lacked a notochord (Fig. 5K) ; MZ15-positive cells were present in the remaining 85% (Fig. 5L) . Finally, expression of XSIP1 in activin-treated animal caps inhibited activininduced convergent extension ( Fig. 5M-P) . In this respect, and in the others described above, the effects of XSIP1 )) causes a down-regulation of Xbra expression in the intact embryo (C) and in activin-treated caps (8 U/ml) (D). (E) Xbra expression is specifically down-regulated by SIP1. Over-expression of ZEB and dEF1 do not affect Xbra expression in the embryo, in contrast to overexpression of XSIP1. Levels of protein, as assayed by Western blot, were similar (data not shown). (F) Down-regulation of Xbra by SIP1 does not require protein synthesis. Control or mSIP1-injected embryos were left untreated or treated with cycloheximide (CHX) just prior to stage 8, collected at different times (h) and assayed for Xbra and chordin expression. mSIP1-injected embryos treated with cycloheximide show a downregulation of Xbra expression comparable to untreated embryos. Chordin expression acts as a positive control for cycloheximide treatment. resemble those of the dominant-interfering Xbra-En R construct (Conlon et al., 1996; Conlon and Smith, 1999) . They suggest that XSIP1 exerts its effects by inhibiting Xbra transcription.
The above data suggest that at early gastrula stages XSIP1 plays a role in mesodermal patterning by regulating expression of Xbra. At later stages XSIP1 is involved in neural development; mis-expression of XSIP1 in animal caps activates expression of NCAM and induces the formation of cement glands (data not shown). These results are consistent with the observations of Eisaki et al. (2000) .
2.4.
Interference with the function of XSIP1; XSIP-VP16 functions as an activator and induces expression of Xbra
Genes belonging to the dEF1 family encode zinc finger containing proteins that function as transcriptional repressors. Our initial efforts to interfere with XSIP1 function by means of antisense morpholino oligonucleotides (Heasman et al., 2000) were unsuccessful (data not shown), so we constructed a mutant protein, XSIP1-VP16, in which the entire XSIP1 coding sequence is fused to the strong activator domain of VP16 (see Brickman et al., 2000) . We anticipated that this chimera, like the analogous construct Hex-VP16 (Brickman et al., 2000) , would interfere with the activity of the wild-type protein.
Consistent with this prediction, expression of XSIP1-VP16 in Xenopus animal caps activates Xbra (Fig. 6A ). This induction does not require protein synthesis and in 
(C) Induction of
Xbra by XSIP1-VP16 does not require protein synthesis. Stage 8 animal caps derived from control embryos or embryos injected with RNA encoding XSIP1-VP16 were left untreated or were exposed to cycloheximide (CHX) for 1 h. They were assayed for Xbra expression at the equivalent of stage 10.5. CHX does not prevent the induction of Xbra, while the same regime was sufficient to prevent induction of chordin by activin (lower panel).
this sense it can be described as 'immediate-early' (Fig. 6C) . Further experiments demonstrated that induction of Xbra by XSIP1-VP16 requires DNA binding, because the creation of point mutations in the third zinc finger of each zinc finger cluster, which results in loss of DNA binding in vitro , prevents activation (data not shown). Animal caps injected with RNA encoding XSIP1-VP16 express the endodermal marker Xsox17a as well as Xbra, but they do not activate Bix4, XWnt8 or goosecoid at the early gastrula stage or muscle-specific actin at late neurula stages (Fig. 6A,B) . XSIP1-VP16 does not induce the neural marker NCAM and even causes a slight reduction in its expression (data not shown). These results suggest that XSIP1-VP16 can inhibit the action of the wild-type protein.
To investigate the function of XSIP1 during embryonic development, embryos were injected at the two-cell stage with RNA encoding XSIP1-VP16. Such embryos developed normally until the early gastrula stage but then failed to complete gastrulation and by tadpole stages, anterior structures were absent (Fig. 7A-F) . These observations are consistent with the observation that over-expression of wild-type XSIP1 inhibits posterior mesoderm formation and induces anterior structures in animal pole tissue and they suggest that XSIP1 is required for formation of anterior neurectoderm, either directly or through interference with gastrulation movements.
The ability of XSIP1-VP16 to induce expression of Xbra was reflected in its morphogenetic effects on Xenopus animal caps. Thus, expression of XSIP1-VP16 caused some elongation of animal caps (Fig. 7G,H ) and co-expression of XSIP1-VP16 and noggin caused even more dramatic elongation (Fig. 7I,J) , reminiscent of the effects of coexpression of Xbra and noggin (Cunliffe and Smith, 1994) . The specificity of the action of the XSIP1-VP16 construct was examined by co-expressing wild-type XSIP1 and the VP16 version. The posterior truncation caused by XSIP1 was rescued by XSIP1-VP16 (Fig. 8A ) and the anterior defects brought about by XSIP1-VP16 were rescued by wild-type XSIP1 (Fig. 8B ).
Discussion
Our results show that the expression patterns of Xbra and XSIP1 overlap at the early gastrula stage, and in particular that the two genes are co-expressed in deep cells above the dorsal blastopore lip. The expression patterns then resolve such that Xbra is expressed in the non-involuting mesoderm and XSIP1 in the neurectoderm. Work described here, and previously (Lerchner et al., 2000; Remacle et al., 1999; Verschueren et al., 1999) , suggest that the two genes affect each other's expression in a dynamic fashion and help differentiate between mesodermal and neural fates.
Dynamic expression of Xbra and XSIP1
Xbra and XSIP1 are co-expressed in deep cells of the dorsal marginal zone of the Xenopus embryo. Expression of both can be induced by mesoderm-inducing factors such as activin, and the similar expression patterns of the two genes in the dorsal marginal zone at the early gastrula stage (Fig. 1) suggest that in this region of the embryo (G-J) Animal cap explants derived from uninjected embryos (G), embryos injected with RNA encoding XSIP1-VP16 (20 pg) (H), embryos injected with RNA encoding noggin (500 pg) (I) and embryos injected with RNA encoding XSIP1-VP16 (20 pg) and noggin (500 pg) (J). Caps were cultured to the equivalent of stage 17. Note that XSIP1-VP16 causes slight convergent extension (H), and that elongation is enhanced by noggin (J). they are subject to similar inducing signals and respond in similar ways. We do not yet know why XSIP1 expression is lower in the ventral and lateral marginal zone regions than in the dorsal marginal zones, although it is possible that this is due to lower concentrations of inducing factors such as Xnr1 (Jones et al., 1995) , Xnr2 (Jones et al., 1995) and Xnr4 (Joseph and Melton, 1997) in the underlying endoderm (Agius et al., 2000) .
After the initial induction of the two genes, further regulatory interactions take place. For example, Xbra can induce (albeit indirectly) expression of both itself (Tada et al., 1997) and of XSIP1 (Fig. 2) . Most significantly, however, XSIP1 represses expression of Xbra and this observation may provide a basis for understanding the mechanism by which the two genes come to occupy different expression domains whose cells go on to follow different fates. Thus, Xbra is expressed in prospective mesoderm and is capable of inducing animal pole cells to adopt mesodermal fates (Cunliffe and Smith, 1992; Cunliffe and Smith, 1994; O'Reilly et al., 1995) , while XSIP1 is expressed in the neurectoderm and is capable of inducing animal pole cells to adopt neural fates (data not shown and Eisaki et al., 2000) .
In attempting to understand how the two genes come to occupy adjacent and non-overlapping expression domains it is not enough that XSIP1 represses Xbra, because this would simply result in a general down-regulation of Xbra in the region of the dorsal blastopore lip. Rather, there must be some mechanism by which an initial asymmetry in expression is reinforced and amplified. Part of this may involve the ability of Xbra to induce its own expression via the activation of eFGF Isaacs et al., 1994; Schulte-Merker and Smith, 1995) . Equally, there may be independent mechanisms which cause down-regulation of XSIP1 in the Xbra-expressing domain and up-regulation of XSIP1 in the prospective neurectoderm. It is possible that the up-regulation of XSIP1 occurs in response to Xnr3 acting in the plane of the ectoderm (Agius et al., 2000) .
The importance of XSIP1, or proteins related to it, in the regulation of Xbra is illustrated by experiments using transgenic Xenopus embryos. Xbra reporter constructs carrying a point mutation in the XSIP1 binding site show widespread mis-expression in ectoderm, and more weakly, in endoderm at the early gastrula stage (Lerchner et al., 2000) . Subsequently, during mid-gastrula stages, expression becomes confined to a ring in the marginal zone mesoderm, but it continues to be mis-expressed in the inner layer of the ectoderm. These results are consistent with the idea that a member of the dEF1 family is involved in the regulation of Xbra, but unless levels of XSIP1 below the limits of detection are sufficient to suppress Xbra, they suggest that XSIP1 cannot be the only member. In particular, the early mis-expression of reporter constructs in the endoderm suggests that there is another vegetally expressed transcription factor with the same binding specificity that represses expression of Xbra.
Effects of over-expression of XSIP1
XSIP1 represses expression of Xbra, and over-expression of XSIP1 in the Xenopus embryo causes defects resembling those observed following inhibition of Xbra function (Conlon et al., 1996; Conlon and Smith, 1999) . In particular, posterior development is disrupted, notochord differentiation is slightly impaired and activin-induced elongation of animal caps is inhibited (Fig. 5 ). There are, however, additional defects in XSIP1-injected embryos that are probably unrelated to the inhibition of Xbra expression, including the defects in eye development (Fig. 5) . These may be due to later effects of XSIP1.
Specific functions of members of the d EF1 family
Our results show a remarkable degree of specificity in the function of XSIP1, in that it can down-regulate expression of Xbra but not the expression of other regulatory genes in the Xenopus embryo such as XWnt8 and goosecoid (Fig. 4) . There is also a high degree of specificity within the dEF1 family, because dEF1 itself and the related ZEB have no discernible effect on Xbra expression (Fig. 3) .
The molecular basis of this specificity is not yet clear. All members of the dEF1 family function as transcriptional repressors in the assays used thus far and all contain two zinc finger clusters which, according to previous work, appear to bind similar DNA sequences (Ikeda and Kawakami, 1995; Remacle et al., 1999; Sekido et al., 1997) . One possibility is that the Smad binding domain (SBD) of XSIP1 confers some specificity, but we have been unable to investigate this issue because deletion of the SBD of SIP1 causes the protein to become unstable. Future work might involve making chimeras between SIP1 and ZEB or between SIP1 and the product of the newly identified zebrafish gene Kheper (Muraoka et al., 2000) . Kheper encodes a protein related to dEF1 which does not affect expression of Ntl, the zebrafish homologue of Brachyury (Schulte-Merker et al., 1994) . Finally, it is possible that the different dEF1 family members associate with different co-factors which modulate the activity of proteins bound to DNA. This is under investigation.
Neural expression of XSIP1
XSIP1 induces isolated animal pole regions to form anterior neural structures (data not shown and Eisaki et al., 2000) . The molecular basis of this observation is unclear. It is unlikely to be due to its ability to repress expression of Xbra, because Xbra is not normally expressed in ectodermal tissue. We do note, however, that a truncated form of Xbra, which might act in a dominant-negative fashion, can neuralise prospective ectodermal tissue (Rao, 1994) . It is not known how this occurs. The role of XSIP1 in neural induction requires further investigation.
Inhibition of XSIP1 function
One approach to studying the role of XSIP1 is to inhibit its function. We were unable to obtain a phenotype using antisense morpholino oligonucleotides (Heasman et al., 2000) , even using oligonucleotides designed to recognise both known alleles of the gene (Eisaki et al., 2000; van Grunsven et al., 2000) . It is possible that the genome of Xenopus laevis contains additional copies of XSIP1, and we are currently searching for the homologue of XSIP1 in the diploid species Xenopus tropicalis.
As an alternative approach to interfere with the action of XSIP1 we designed a construct in which the VP16 activation domain is fused to the entire XSIP1 open reading frame. Similar constructs based on the homeobox-containing gene Hex have been shown to act in a dominant-negative fashion (Brickman et al., 2000) , and indeed our XSIP1-VP16 construct proved to activate expression of Xbra in Xenopus animal caps in a direct fashion (Fig. 6) . Interestingly, XSIP1-VP16 also proved to activate expression of Xsox17a , although wild-type XSIP1 did not cause a down-regulation of this gene. One explanation for this observation is that XSIP1 requires a co-repressor to downregulate expression of Xsox17a , while no cofactor would be required by XSIP1-VP16. As well as activating expression of Xbra, XSIP1-VP16 proved to possess some of the properties of Xbra, including the ability to induce elongation of Xenopus animal caps and to be able to synergise with noggin in doing so (Fig. 7 and Cunliffe and Smith, 1994) .
Expression of XSIP1-VP16 in intact embryos shed light on the function of XSIP1 during normal development. We distinguish two effects, one early and one late. At early stages, we observe that interference with XSIP1 function disrupts gastrulation (Fig. 7) , as does over-expression of Xbra (Cunliffe and Smith, 1992) . At later stages embryos expressing XSIP1-VP16 lack anterior structures and might be said to have the 'opposite' phenotype to embryos expressing the wild-type protein. Our experiments suggest that at least some of the early effects of XSIP1 occur through its action on Xbra; it will be interesting to identify other targets of XSIP1 at later stages, during neural development.
Experimental procedures
Xenopus embryos, microinjection and dissection
Xenopus embryos were obtained by in vitro fertilisation (Smith and Slack, 1983) . They were maintained in 10% normal amphibian medium (NAM: Slack, 1984) and staged according to Nieuwkoop and Faber (1975) . Embryos at the one-cell or two-cell stage were injected with RNA as described (Smith, 1993) . Protein synthesis inhibition experiments were performed as described (Smith et al., 1991) except that cycloheximide was applied for 1 h at a concentration of 10 mg/ml. This treatment typically inhibits incorporation of [ 35 S] methionine into acid-precipitable material by over 95%. Activin treatment of animal pole regions used partially purified material obtained from CHO cells transfected with human activin b A . A unit of activin activity is defined by Cooke et al. (1987) .
Plasmid constructs and in vitro transcription
mSIP1 RNA was prepared as described . The plasmids pCS2.XSIP1 and pCS2.XSIP1-VP16 were created by means of the polymerase chain reaction (PCR) as follows: MunI and XhoI sites were engineered into the 5 0 and 3 0 ends, respectively, of the XSIP1 cDNA (forward: ACG GCA ATT GAT GAA GCA AGA GAT CAT GGC GGA TGG; reverse: CTG ACT CGA GTG CAG TAG TCA ATT ACA TGC CAT CCT CC) (van Grunsven et al., 2000) . The PCR product was cloned in frame into the EcoRI/XhoI sites of pCS2 including six myc tags. No differences were observed between use of XSIP1 and mSIP1 in the experiments described in this paper. XSIP1-VP16 was constructed by adding two copies of the VP16 minimal transcriptional activation domain (Brickman et al., 2000) to the pCS2.mycXSIP1 construct.
As a control, we prepared a version of XSIP1-VP16 carrying two point mutations in the third zinc finger of each zinc finger cluster. Cloning details are available on request. RNA encoding noggin (Smith and Harland, 1992) , a dominant-negative BMP4 receptor (tBR) (Graff et al., 1994) and Xbra-HA (Tada et al., 1997) , was prepared as described (Smith, 1993) .
RNA isolation and RNAase protection assays
RNAase protection analyses were carried out as described (Jones et al., 1995) using RNAase T1 alone. Samples were analysed with probes specific for Xbra (Smith et al., 1991) , goosecoid (Blumberg et al., 1991) , Xwnt8 (Christian et al., 1991) , Xwnt11 , Bix4 (Casey et al., 1999) , Xvent1 (Gawantka et al., 1995) , chordin (Sasai et al., 1994) , Xsox17a (Hudson et al., 1997) , NCAM (Kintner and Melton, 1987) , ODC (Isaacs et al., 1992) and XSIP1 (van Grunsven et al., 2000) .
In situ hybridisation and immunohistochemistry
Whole-mount in situ hybridisation was performed as described (Harland, 1991) except that Boehringer Mannheim (BM) purple was used as substrate and RNAase treatment was omitted. An XSIP1 probe was prepared using a construct in which an XSIP1 cDNA fragment (2476-3194) was cloned into the vector pCRscript. The plasmid was linearised with Pst1 and transcribed with T3 RNA polymerase. A Bix4 probe was prepared by linearising pBix4 with BamH1 and transcribing with T7 RNA polymerase. The Xbra, goosecoid and Xwnt11 probes were as described . To prepare sectioned specimens, samples were fixed in 4% paraformaldehyde for 2 h at room temperature and then dehydrated, embedded in wax and cut at 10 mm. Whole-mount immunohistochemistry was carried out using the monoclonal antibody MZ15, specific for notochord (Smith and Watt, 1985) , and a rabbit polyclonal antibody specific for Xbra protein (Tada et al., 1998) . Immunolocalisation of the lineage tracer FLDx was carried out as described (Jones and Smith, 1998) .
